{"id":"https://openalex.org/W3045286646","doi":null,"title":"Recent Trends in the Separation of Chiral Drugs","display_name":"Recent Trends in the Separation of Chiral Drugs","publication_year":2019,"publication_date":"2019-01-01","ids":{"openalex":"https://openalex.org/W3045286646","mag":"3045286646"},"language":"en","primary_location":{"id":"mag:3045286646","doi":null,"is_oa":false,"landing_page_url":"https://www.openaccessjournals.com/articles/recent-trends-in-the-separation-of-chiral-drugs.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082968627","display_name":"Thomas Sudha","orcid":"https://orcid.org/0000-0001-8821-3999","observed_orcids":["https://orcid.org/0000-0001-8821-3999"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"T. Sudha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5082968627"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"2","issue":"2","first_page":"03","last_page":"04"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10013","display_name":"Asymmetric Synthesis and Catalysis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12748","display_name":"Molecular spectroscopy and chirality","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/enantiomeric-separation","display_name":"enantiomer separation","score":0.843999981880188},{"id":"https://openalex.org/keywords/enantiomers","display_name":"enantiomers","score":0.8709999918937683},{"id":"https://openalex.org/keywords/racemic-drugs","display_name":"racemic drugs","score":0.8899999856948853},{"id":"https://openalex.org/keywords/chiral-hplc","display_name":"chiral HPLC","score":0.9179999828338623},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6769999861717224},{"id":"https://openalex.org/keywords/propranolol","display_name":"propranolol","score":0.703000009059906},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.781000018119812},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.5320000052452087},{"id":"https://openalex.org/keywords/enantiomeric-purity","display_name":"enantiomeric purity","score":0.453000009059906}],"concepts":[{"id":"https://openalex.org/C486523","wikidata":"https://www.wikidata.org/wiki/Q494483","display_name":"Enantiomer","level":2,"score":0.8733413815498352},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.671177864074707},{"id":"https://openalex.org/C2781047461","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutical","level":2,"score":0.5506125688552856},{"id":"https://openalex.org/C2781219336","wikidata":"https://www.wikidata.org/wiki/Q467717","display_name":"Racemic mixture","level":3,"score":0.5337828993797302},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.5257109999656677},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5076225996017456},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4683000147342682},{"id":"https://openalex.org/C146686406","wikidata":"https://www.wikidata.org/wiki/Q898628","display_name":"Enantioselective synthesis","level":3,"score":0.46519291400909424},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.42358309030532837},{"id":"https://openalex.org/C16838498","wikidata":"https://www.wikidata.org/wiki/Q5101828","display_name":"Chiral column chromatography","level":3,"score":0.422167032957077},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3825477361679077},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.2443542182445526},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.17066344618797302},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.08586433529853821},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.08246389031410217},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3045286646","doi":null,"is_oa":false,"landing_page_url":"https://www.openaccessjournals.com/articles/recent-trends-in-the-separation-of-chiral-drugs.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.5683000087738037,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2612003706","https://openalex.org/W4390049991","https://openalex.org/W4323310325","https://openalex.org/W7100867671","https://openalex.org/W3024122593","https://openalex.org/W7083593451","https://openalex.org/W1991415274","https://openalex.org/W2891962642","https://openalex.org/W2943007134","https://openalex.org/W19842843"],"abstract_inverted_index":{"Many":[0],"of":[1,10,22,38,83,106,115,205,217,225,238],"the":[2,15,19,61,75,79,143,186,196,200,236],"currently":[3],"used":[4,179,214],"drugs":[5,67,86,110,169,227,268],"in":[6,27,45,68,71,121,232,249,255,276],"practice":[7],"are":[8,182,213],"mixtures":[9],"enantiomers.":[11,206],"Although":[12],"they":[13],"have":[14],"same":[16],"chemical":[17],"structure,":[18],"enantiomeric":[20],"forms":[21],"a":[23,150,229,246,287],"drug":[24],"can":[25,87],"differ":[26],"potency,":[28],"selectivity":[29],"for":[30,199,215],"receptors,":[31],"transporters":[32],"and":[33,42,52,64,92,108,154,174,191,203,210,243,286],"/":[34],"or":[35,219],"enzymes,":[36],"rate":[37,105],"metabolism,":[39],"metabolites,":[40],"excretion":[41],"toxicity,":[43],"behavior":[44],"biological":[46],"systems":[47],"(like":[48],"pharmacokinetics,":[49],"bioavailability,":[50],"efficacy":[51],"biopharmaceutical":[53],"parameters).":[54],"Therefore,":[55],"it":[56,164],"is":[57,118,134,228,259],"important":[58,261],"to":[59,73,90,103,262,272,278,281],"promote":[60],"chiral":[62,147,168,218,223,240,267],"separation":[63,148,155,202,224,241],"analysis":[65,204],"racemic":[66,220,226,270],"pharmaceutical":[69,233],"industry,":[70],"order":[72,277],"eliminate":[74],"unwanted":[76],"isomer":[77,176],"from":[78],"preparation.":[80],"The":[81,207,222],"use":[82],"single":[84],"enantiomer":[85,172],"potentially":[88],"lead":[89],"simpler":[91,100],"more":[93,119,137,264],"selective":[94],"pharmacologic":[95],"profiles":[96],"included":[97],"therapeutic":[98,289],"indices,":[99],"pharmacokinetics":[101],"due":[102],"different":[104],"metabolism":[107],"decreased":[109],"interactions.":[111],"For":[112],"example,":[113],"Levorotary\u2013isomer":[114],"all":[116],"\u03b2-blockers":[117],"potent":[120],"blocking":[122],"\u03b2":[123],"-":[124],"adrenoceptors":[125],"than":[126,139],"their":[127],"dextrorotaryisomer,":[128],"such":[129],"as":[130,159,161,252,254],"S":[131],"(-)":[132],"-propranolol":[133],"100":[135],"times":[136],"active":[138],"its":[140],"R":[141],"(+)-antipode.\r\n\r\nIn":[142],"early":[144],"period":[145],"analytical":[146],"was":[149,165],"rather":[151],"difficult":[152],"task":[153],"methods":[156,198],"were":[157],"not":[158],"advanced":[160],"today.":[162],"Nevertheless,":[163],"clear":[166],"that":[167],"should":[170,177],"be":[171,178,245],"separated":[173,183],"each":[175],"separately.":[180],"Enantiomers":[181],"by":[184],"using":[185],"modern":[187],"techniques":[188,242],"like":[189],"HPLC":[190,193],"Chiral":[192],"has":[194],"proven":[195],"best":[197],"direct":[201],"physical":[208],"method":[209],"enantioselective":[211],"immunoassays":[212],"characterization":[216],"drugs.":[221],"necessary":[230],"operation":[231],"industry.":[234],"Therefore":[235],"development":[237],"new":[239],"will":[244],"topic":[247],"subject":[248],"academic":[250],"research":[251],"well":[253],"industrial":[256],"advance.":[257],"It":[258],"also":[260],"give":[263],"information":[265],"about":[266],"especially":[269],"form":[271],"health":[273],"care":[274],"professionals":[275],"help":[279],"them":[280],"finding":[282],"an":[283],"optimal":[284],"treatment":[285],"right":[288],"control.":[290]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2020-07-29T00:00:00"}